VRTX

#133
Vertex Pharmaceuticals Incorporated - Common Stock
444.3 1 USD
-0.82%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
443.02
449.27
Range Annuel
374.17
507.92
Changement quotidien
-0.82%
Changement Mensuel
+4.72%
Evolution sur 6 mois
+2.87%
Changement Annuel
-0.74%
Clôture Précédente
447.9 7
Open
448.0 0
Low
443.0 2
High
449.2 7
Volume
440
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 112.77 B
  • Employee 6 400
  • Founded 1989
  • CEO Reshma Kewalramani
  • Website www.vrtx.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000C1S2X2
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
29.59
ratio cours/chiffre d'affaires
9.75

Vertex Pharmaceuticals Incorporated - Common Stock

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

Nouvelles